FDC Limited (BOM:531599)
368.35
-5.40 (-1.44%)
At close: Mar 5, 2026
FDC Limited Market Cap
FDC Limited has a market cap or net worth of 59.97 billion as of March 5, 2026. Its market cap has decreased by -16.29% in one year.
Market Cap
59.97B
Enterprise Value
55.93B
Revenue
20.78B
Ranking
n/a
PE Ratio
27.70
Stock Price
368.35
Market Cap Chart
Since May 30, 2002, FDC Limited's market cap has increased from 2.73B to 59.97B, an increase of 2,098.73%. That is a compound annual growth rate of 13.88%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 5, 2026 | 59.97B | -12.98% |
| Dec 31, 2025 | 68.92B | -15.14% |
| Dec 31, 2024 | 81.22B | 25.96% |
| Dec 29, 2023 | 64.48B | 43.15% |
| Dec 30, 2022 | 45.04B | -12.27% |
| Dec 31, 2021 | 51.34B | -8.36% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Granules India | 137.16B |
| Jubilant Pharmova | 131.98B |
| Rubicon Research | 125.77B |
| Caplin Point Laboratories | 125.45B |
| CORONA Remedies | 96.63B |
| Sanofi India | 88.14B |
| Viyash Scientific | 87.86B |
| Procter & Gamble Health | 80.83B |